Akzo Nobel Shares Gain After Rs 2,143-Crore Intergroup Deal
Shares of Akzo Nobel India Ltd. gained on Tuesday, after the company announced that it will transfer its powder coatings business and international research and development centre to its Dutch parent firm Akzo Nobel NV in a Rs 2,143-crore intergroup deal, to streamline the company's business.
The company's board of directors accepted the binding offer from AkzoNobel NV, which includes Rs 2,073-crore slump sale of the powder coatings business and Rs 70 crore transfer of the international research centre, according to a late night regulatory filing on Monday.
The company has accepted the sale and transfer of ANIL's powder coatings business and the international R&D on a slump sale basis as a going concern. This will allow ANIL to strengthen its position in its liquid paints and coatings business, while divesting its existing non-core assets.
"Each of the aforesaid slump sale transactions will be undertaken through separate business transfer agreements, with an indirect wholly owned subsidiary of Akzo Nobel NV," it added.
ANIL's board had received the binding offer letter from Akzo Nobel NV, the ultimate holding or promoter company of the paint maker on Monday.
In addition, AkzoNobel India will acquire intellectual property rights of Akzo Nobel Coatings International BV for its decorative paints business in India, Bangladesh, Bhutan, and Nepal for a consideration of Rs 1,152 crore.
"These transactions will make Akzo Nobel India a more focused liquid paints and coatings business and enable it to become a fully brand-and-technology-independent company, for its core decorative paints business," the company said in the filing.
However, it added that the execution of these transactions is subject to approval of the shareholders of Akzo Nobel India and the supervisory board of Akzo Nobel NV.
ANIL will seek its shareholders' approval in the coming weeks, with the voting process expected to conclude a month later, the filing said.
Akzo Nobel India Share Price

Shares of Akzo Nobel India rose as much as 2.33%, before paring gains to trade 1.28% higher at Rs 3,315.55 apiece, as of 1:52 p.m. This compares to a 0.17% advance at the NSE Nifty 50.
The stock has risen 21.12% in the last 12 months. Total traded volume so far in the day stood at 0.02 times its 30-day average. The relative strength index was at 40.47.
One out of two analysts tracking the company maintains a 'buy' rating and one recommends a 'hold', according to Bloomberg data. The average of 12-month analysts' price targets implies a potential upside of 18.6%.
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern Washington-New Delhi relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets
-
India Is Going Abroad For Critical Minerals. But It May Take Years To Pay Off | The Reason Why
Although India's steps are in the right direction, they remain modest compared with India's growing dependence.
-
When Everyone Has AI, What Gives You An Edge?
India's young workforce is entering an uncertain world of work where powerful AI tools are becoming widely accessible. The advantage will belong to those who combine deep expertise with digital fluency, and the distinctly human capabilities that technology cannot manufacture.
-
Wrong Labels, High Pesticide Residues Holding Back Agri Exports | The Reason Why
India needs stronger domestic food-safety and labelling standards, with best practices becoming part of everyday business for farmers, traders and food companies.